AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. StemCell Institute Inc.
  3. Financials
  4. Revenue growth (%)

StemCell Institute Inc.【JP:7096】

Market cap
¥9.3B
P/E ratio
28.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20258-57.19%
Mar 31, 202418.6+7.37%
Mar 31, 202317.4-34.29%
Mar 31, 202226.4-265.95%
Mar 31, 2021-15.9-134.76%
Mar 31, 202045.8+36.84%
Mar 31, 201933.5+395.85%
Mar 31, 20186.8-3.02%
Mar 31, 20177

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)